Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 398

1.

Paradigm shift in surgery for benign parotid tumors: 19 years of experience with almost 3000 cases.

Bär B, Mantsopoulos K, Iro H.

Laryngoscope. 2019 Dec 5. doi: 10.1002/lary.28454. [Epub ahead of print]

PMID:
31804719
2.

Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1).

Semrau S, Schmidt D, Hecht M, Haderlein M, Kitzsteiner C, Müller S, Traxdorf M, Agaimy A, Iro H, Kuwert T, Fietkau R.

Oral Oncol. 2019 Nov 28;100:104479. doi: 10.1016/j.oraloncology.2019.104479. [Epub ahead of print]

PMID:
31786390
3.

Fusion of Preoperative MRI and Postoperative FD-CT for Direct Evaluation of Cochlear Implants : An Analysis at 1.5 T and 3 T.

Eisenhut F, Taha L, Kleibe I, Hornung J, Iro H, Doerfler A, Lang S.

Clin Neuroradiol. 2019 Nov 21. doi: 10.1007/s00062-019-00853-6. [Epub ahead of print]

PMID:
31754757
4.

Complex midfacial defects: Is the extended Abbé flap the ideal solution to a tough problem?

Mantsopoulos K, Iro H, Constantinidis J.

Oral Oncol. 2019 Nov 1:104470. doi: 10.1016/j.oraloncology.2019.104470. [Epub ahead of print]

PMID:
31685290
5.

Paragangliomas of the Head and Neck: Local Control and Functional Outcome Following Fractionated Stereotactic Radiotherapy.

Weissmann T, Lettmaier S, Roesch J, Mengling V, Bert C, Iro H, Hornung J, Janka R, Semrau S, Fietkau R, Putz F.

Am J Clin Oncol. 2019 Nov;42(11):818-823. doi: 10.1097/COC.0000000000000614.

PMID:
31592806
6.

Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year results.

Breheret M, Lubgan D, Haderlein M, Hecht M, Traxdorf M, Schmidt D, Müller S, Kitzsteiner C, Kuwert T, Iro H, Fietkau R, Semrau S.

Eur Arch Otorhinolaryngol. 2019 Oct 3. doi: 10.1007/s00405-019-05665-5. [Epub ahead of print]

PMID:
31583430
7.

Merged Volume Rendered Flat-panel Computed Tomography for Postoperative Cochlear Implant Assessment.

Eisenhut F, Lang S, Taha L, Doerfler A, Iro H, Hornung J.

Clin Neuroradiol. 2019 Sep 5. doi: 10.1007/s00062-019-00832-x. [Epub ahead of print]

PMID:
31489450
8.

Response to Letter to the editor: Interrater Reliability of Ultrasound in the Diagnosis of Sialolithiasis: Methodological Issues. Interrater Reliability of Ultrasound: Methodological Issues.

Goncalves M, Mantsopoulos K, Schapher ML, Iro H, Koch M.

Ultraschall Med. 2019 Oct;40(5):658. doi: 10.1055/a-0976-9130. Epub 2019 Aug 22. No abstract available.

PMID:
31437856
9.

Escalation in mucus cystatin 2, pappalysin-A, and periostin levels over time predict need for recurrent surgery in chronic rhinosinusitis with nasal polyps.

Mueller SK, Wendler O, Nocera A, Grundtner P, Schlegel P, Agaimy A, Iro H, Bleier BS.

Int Forum Allergy Rhinol. 2019 Oct;9(10):1212-1219. doi: 10.1002/alr.22407. Epub 2019 Aug 20.

PMID:
31430426
10.

Outcome and management of rare high-grade "salivary" adenocarcinoma: the important role of adjuvant (chemo)radiotherapy.

Scherl C, Haderlein M, Agaimy A, Mantsopoulos K, Koch M, Traxdorf M, Fietkau R, Grundtner P, Iro H.

Strahlenther Onkol. 2019 Dec;195(12):1050-1059. doi: 10.1007/s00066-019-01499-6. Epub 2019 Jul 26.

PMID:
31350567
11.

Parotid pleomorphic adenomas: Factors influencing surgical techniques, morbidity, and long-term outcome relative to the new ESGS classification in a retrospective study.

Schapher M, Koch M, Agaimy A, Goncalves M, Mantsopoulos K, Iro H.

J Craniomaxillofac Surg. 2019 Sep;47(9):1356-1362. doi: 10.1016/j.jcms.2019.06.009. Epub 2019 Jun 26.

PMID:
31331850
12.

[Hearing aid provision - can the limited obligation of statutory health insurance to provide indemnification only up to the reference price be successfully challenged in the social courts in cases of medical indication?]

Lottner A, Iro H, Schützenberger A, Hoppe U.

Laryngorhinootologie. 2019 Oct;98(10):708-714. doi: 10.1055/a-0964-8969. Epub 2019 Jul 16. Review. German.

PMID:
31311038
13.

Intraductal lithotripsy in sialolithiasis with two different Ho:YAG lasers: presetting parameters, effectiveness, success rates.

Koch M, Hung SH, Su CH, Lee KS, Iro H, Mantsopoulos K.

Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5548-5557. doi: 10.26355/eurrev_201907_18288.

14.

Completion surgery after extracapsular dissection of low-grade parotid gland malignant tumors.

Mantsopoulos K, Mueller S, Goncalves M, Koch M, Iro H.

Head Neck. 2019 Sep;41(9):3383-3388. doi: 10.1002/hed.25863. Epub 2019 Jul 5.

PMID:
31273890
15.

Transoral Ultrasound in the Diagnosis of Obstructive Salivary Gland Pathologies.

Schapher M, Goncalves M, Mantsopoulos K, Iro H, Koch M.

Ultrasound Med Biol. 2019 Sep;45(9):2338-2348. doi: 10.1016/j.ultrasmedbio.2019.05.019. Epub 2019 Jun 18.

PMID:
31227261
16.

Does increasing the incidence of extracapsular dissection for benign tumors of the parotid correlate with an increased need for revision surgery?

Mantsopoulos K, Mueller SK, Goncalves M, Schapher M, Koch M, Iro H.

Oral Oncol. 2019 Jul;94:111-114. doi: 10.1016/j.oraloncology.2019.05.022. Epub 2019 May 29.

PMID:
31178205
17.

Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.

Haller F, Skálová A, Ihrler S, Märkl B, Bieg M, Moskalev EA, Erber R, Blank S, Winkelmann C, Hebele S, Baněčková M, Wiemann S, Müller S, Zenk J, Eils R, Iro H, Hartmann A, Agaimy A.

Am J Surg Pathol. 2019 Sep;43(9):1264-1272. doi: 10.1097/PAS.0000000000001279.

PMID:
31094928
18.

Watchful waiting in carefully selected metachronous cystadenolymphomas of the parotid gland: a reliable option?

Mantsopoulos K, Goncalves M, Koch M, Iro H.

Br J Oral Maxillofac Surg. 2019 Jun;57(5):425-429. doi: 10.1016/j.bjoms.2018.12.018. Epub 2019 Apr 20.

PMID:
31014677
19.

Salivary gland carcinoma (SGC) with perineural spread and/or positive resection margin - high locoregional control rates after photon (chemo) radiotherapy - experience from a monocentric analysis.

Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Putz F, Iro H, Agaimy A, Fietkau R.

Radiat Oncol. 2019 Apr 23;14(1):68. doi: 10.1186/s13014-019-1260-x.

20.

Survival benefit for patients treated in a certified head and neck tumor center.

von Wilmowsky C, Traxdorf M, Adler W, Neukam FW, Iro H, Nkenke E, Kesting M, Wurm M.

Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2863-2869. doi: 10.26355/eurrev_201904_17564.

Supplemental Content

Support Center